Cheryl L. Marks

924 total citations · 1 hit paper
12 papers, 516 citations indexed

About

Cheryl L. Marks is a scholar working on Molecular Biology, Neurology and Genetics. According to data from OpenAlex, Cheryl L. Marks has authored 12 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Neurology and 3 papers in Genetics. Recurrent topics in Cheryl L. Marks's work include Neuroblastoma Research and Treatments (3 papers), Probiotics and Fermented Foods (2 papers) and Animal testing and alternatives (2 papers). Cheryl L. Marks is often cited by papers focused on Neuroblastoma Research and Treatments (3 papers), Probiotics and Fermented Foods (2 papers) and Animal testing and alternatives (2 papers). Cheryl L. Marks collaborates with scholars based in United States, France and Canada. Cheryl L. Marks's co-authors include Juan M. Lopez, Ernst Freese, Virginia M. Miller, Kathryn Sandberg, Terri L. Cornelison, Janine A. Clayton, Margaret M. McCarthy, Londa Schiebinger, Cora Lee Wetherington and Susan L. Makris and has published in prestigious journals such as Journal of Biological Chemistry, Cancer Research and Oncogene.

In The Last Decade

Cheryl L. Marks

12 papers receiving 485 citations

Hit Papers

Considering sex as a biological variable in preclinical r... 2016 2026 2019 2022 2016 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cheryl L. Marks United States 6 196 124 74 52 43 12 516
Osamu Asami Japan 14 327 1.7× 70 0.6× 17 0.2× 21 0.4× 41 1.0× 22 942
Caroline Underhill Canada 14 410 2.1× 148 1.2× 49 0.7× 26 0.5× 11 0.3× 19 847
Maren Lang Germany 12 405 2.1× 73 0.6× 24 0.3× 15 0.3× 35 0.8× 20 669
Maria Carmela Latella Italy 15 304 1.6× 143 1.2× 36 0.5× 26 0.5× 12 0.3× 22 633
Catherine Grégoire France 11 300 1.5× 33 0.3× 20 0.3× 30 0.6× 15 0.3× 13 572
Anthony Nicholson Australia 10 154 0.8× 68 0.5× 60 0.8× 7 0.1× 60 1.4× 17 608
Matthew F. Taylor United Kingdom 12 199 1.0× 55 0.4× 90 1.2× 7 0.1× 10 0.2× 18 515
E. Battaner Spain 17 494 2.5× 47 0.4× 17 0.2× 16 0.3× 13 0.3× 22 806
Donna Shattuck United States 12 417 2.1× 240 1.9× 26 0.4× 34 0.7× 7 0.2× 14 955
Huifen Zhao Canada 21 626 3.2× 551 4.4× 88 1.2× 9 0.2× 36 0.8× 40 1.6k

Countries citing papers authored by Cheryl L. Marks

Since Specialization
Citations

This map shows the geographic impact of Cheryl L. Marks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheryl L. Marks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheryl L. Marks more than expected).

Fields of papers citing papers by Cheryl L. Marks

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheryl L. Marks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheryl L. Marks. The network helps show where Cheryl L. Marks may publish in the future.

Co-authorship network of co-authors of Cheryl L. Marks

This figure shows the co-authorship network connecting the top 25 collaborators of Cheryl L. Marks. A scholar is included among the top collaborators of Cheryl L. Marks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheryl L. Marks. Cheryl L. Marks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Miller, Leah, Cheryl L. Marks, Jill B. Becker, et al.. (2016). Considering sex as a biological variable in preclinical research. The FASEB Journal. 31(1). 29–34. 281 indexed citations breakdown →
2.
Marks, Cheryl L.. (2009). Mouse Models of Human Cancers Consortium (MMHCC) from the NCI. Disease Models & Mechanisms. 2(3-4). 111–111. 12 indexed citations
3.
Marks, Cheryl L.. (2006). Animal Models for Human Diseases: Is There a Future Without Them?. 47(12). 1 indexed citations
4.
Marks, Cheryl L. & Peter S. Conti. (2006). Session 4: Instrumentation and Animal Models. 47(12). 1 indexed citations
5.
Xu, Fei, Himanso Sahni, Ajay Gupta, et al.. (2004). Neuroblastoma differentiation is regulated by cooperation of the RET and TRKA signaling pathways. Cancer Research. 64. 1111–1111. 1 indexed citations
6.
Weiss, William A., Mark A. Israel, Eric C. Holland, et al.. (2002). Neuropathology of genetically engineered mice: consensus report and recommendations from an international forum. Oncogene. 21(49). 7453–7463. 50 indexed citations
7.
Martin, Michael R., et al.. (1990). An Overview of Tumor Biology. Cancer Investigation. 8(1). 71–90. 5 indexed citations
8.
Kimes, Brian W., et al.. (1989). An Overview of Tumor Biology. Cancer Investigation. 7(3). 247–265. 2 indexed citations
9.
Lopez, Juan M., Cheryl L. Marks, & Ernst Freese. (1979). The decrease of guanine nucleotides initiates sporulation of Bacillus subtilis. Biochimica et Biophysica Acta (BBA) - General Subjects. 587(2). 238–252. 131 indexed citations
10.
Freese, Elisabeth Bautz & Cheryl L. Marks. (1973). Developmental Block in Citric Acid Cycle Mutants of Bacillus subtilis. Journal of Bacteriology. 116(3). 1466–1468. 14 indexed citations
11.
Hung, P.P., et al.. (1965). The Biosynthesis and Metabolism of Erythromycins by Streptomyces erythreus. Journal of Biological Chemistry. 240(3). 1322–1326. 17 indexed citations
12.
Hung, P.P., et al.. (1965). Isolation and Characterization of a New Antibiotic, ABBOTT 29119, from Streptomyces erythreus. Applied Microbiology. 13(2). 216–217. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026